Infections, Bacterial

Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax

Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

Therapeutic Options for CRAB

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era

Challenge Non-Typhoidal Salmonella (CHANTS) Study

A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS

Microbiome Analysis of Dental Biofilm on High-Density Polytetrafluoroethylene Membranes Used in Socket Preservation

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial

Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients

Drug-drug Interaction Study of Gepotidacin

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function

Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)